Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Felicia, Goldstein"'
Autor:
Brian Jones, Cristina Drenkard, Charmayne Dunlop-Thomas, Laura Plantinga, Ann Vandenberg, Felicia Goldstein, Jeremy Johnson, Christopher Barrett Bowling, Sung Sam Lim
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Objective To determine whether and how cognitive assessment data should be included in a report for patients with SLE and their providers.Methods Leveraging experiences from prior studies, we created a cognitive report that included a hypothetical pa
Externí odkaz:
https://doaj.org/article/38c1a416d96c4b36aa4fefd16e38259a
Autor:
Qixiang Lin, Salman Shahid, Antoine Hone‐Blanchet, Shuai Huang, Junjie Wu, Aditya Bisht, David Loring, Felicia Goldstein, Allan Levey, Bruce Crosson, James Lah, Deqiang Qiu
Publikováno v:
Human Brain Mapping. 44:3072-3083
Autor:
Ke, Cao, Allison A, Bay, Ihab, Hajjar, Whitney, Wharton, Felicia, Goldstein, Deqiang, Qiu, Todd, Prusin, J Lucas, McKay, Molly M, Perkins, Madeleine E, Hackney
Publikováno v:
J Alzheimers Dis
Background: Functional decline in Alzheimer’s disease (AD) is impacted by impaired ability to integrate and modulate complex cognitive and motor abilities, commonly known as motor-cognitive integration. Impaired motor-cognitive integration occurs i
Publikováno v:
Monday, April 24.
Autor:
Antoine Hone-Blanchet, Anastasia Bohsali, Lisa C. Krishnamurthy, Salman S. Shahid, Qixiang Lin, Liping Zhao, Aditya S. Bisht, Samantha E. John, David Loring, Felicia Goldstein, Allan Levey, James Lah, Deqiang Qiu, Bruce Crosson
Publikováno v:
J Alzheimers Dis
Background: Women account for two thirds of the prevalence and incidence of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Evidence suggest that sex may differently influence the expression of proteins amyloid-beta (Aβ1–42) and ta
Autor:
James Lah, Raghav Tandon, Liping Zhao, Caroline Watson, Morgan Elmor, Craig Heilman, Katherine Sanders, Chadwick Hales, Huiying Yang, David Loring, Felicia Goldstein, John Hanfelt, Duc Duong, Erik C.B. Johnson, Aliza Wingo, Thomas Wingo, Blaine Roberts, Nicholas Seyfried, Allan Levey, Cassie Mitchell
Alzheimer’s disease (AD) progresses through a lengthy asymptomatic period during which pathological changes accumulate prior to development of clinical symptoms. As disease-modifying treatments are developed, tools to stratify risk of clinical dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f971215c05f5c54db865c388b0c1a24a
https://doi.org/10.21203/rs.3.rs-2577025/v1
https://doi.org/10.21203/rs.3.rs-2577025/v1
Autor:
Carl Chiang, Jacquelynn Copeland, Vanessa Raymont, Peter Connelly, Reto Kressig, Guy G. Potter, Daniel K. Burns, Stephen Pearson, Manish Saxena, Ann M. Saunders, Debra Fleischman, DeRen Huang, Thomas Leyhe, Gabriel Leger, Gigi Lefebvre, Mardik Donikyan, Natalie Denburg, Alex Knopman, Nancy Voight, James Burke, Philip Moore, James R. Burke, Margaret Newson, Stephen Haneline, Adam J. Schwarz, George Demakis, Joseph Butchart, Robert Mitchell, Mark Leibowitz, Michael Woodward, Robert Alexander, Concetta Forchetti, Emiliangelo Ratti, Andreas U. Monsch, Lon S. Schneider, Aaron Ritter, Joscelyn Agron-Figueroa, Fraser Inglis, Craig Curtis, Judith Neugroschl, Geraint Price, Mark Brody, Clark Johnson, Clive Ballard, Stephen Thein, Meredith Culp, Kristine Yaffe, Ahad Sabet, Walter Braude, Gregory Kirk, David Krefetz, Rupert Noad, Omid Omidvar, John Sass, Brenda L. Plassman, James Bergthold, Arne Klostermann, Haydn Till, Aaron Ellenbogen, Patrick Harrigan, Heinz-Peter Herbst, Joseph Kass, Lorna Wallace, Jennifer Robinson, Elliot Henderson, Felicia Goldstein, Christopher McWilliam, R. Clarnette, Jerry Halsten, Dan Rujescu, Silvana Micallef, Nestor Galvez-Jimenez, Jeffrey Ross, Dag Aarsland, Hugh Miller, Theresa Campbell, Jingtao Wu, Allan Levey, Liebhild Stratmann, Rosalyn Lai, Agnes Flöel, Richard Shingleton, Steve Higham, Pierre N. Tariot, Esteban Olivera, Sandra Carusa, Amanda Olley, Ricky Mofsen, Kathryn Goozee, Kara Lyons, Richard J. Brown, Marwan N. Sabbagh, Virginia De Sanctis, Jerome Goldstein, Hamid R. Sohrabi, Lefkos T. Middleton, Eugen Schlegel, Donna Munic-Miller, Sylvia Robinson, David Watson, Oda Ackermann, Ralph Votolato, Peter Bailey, Paul Massman, Daniel Gruener, Robert Perneczky, Frederick Schaerf, Craig W. Ritchie, Scott Losk, Christina Zimmerman, Mario Parra, Jill Crusey, Edward Zamrini, Christine Belden, Thomas Arnold, Alexander White, Linda Rice, Elizabeth Coulthard, Jane Martin, Anne Koplin, Rebecca Evans, Janet O'Neil, Oliver Peters, Raj Shah, Marshall Nash, Ronald Bradley, Kathleen A. Welsh-Bohmer, Howard Hassman, Scott Barton, Robert Cohen, Robert Stephenson, Jacobo Mintzer, Michael W. Lutz, Wendy Bond, Rachelle S. Doody, Ronald Hofner, Laura Samson
Publikováno v:
The Lancet Neurology. 20:537-547
Background: The identification of people at risk of cognitive impairment is essential for improving recruitment in secondary prevention trials of Alzheimer's disease. We aimed to test and qualify a biomarker risk assignment algorithm (BRAA) to identi
Multidimensional Environmental Factors and Sleep Health for Aging Adults: A Focused Narrative Review
Autor:
Eunhwa Yang, Aliaa Ismail, Yujin Kim, Ece Erdogmus, Julie Boron, Felicia Goldstein, Jennifer DuBose, Craig Zimring
Publikováno v:
International Journal of Environmental Research and Public Health. 19:15481
The timing, amount, and quality of sleep are critical for an individual’s health and quality of life. This paper provides a focused narrative review of the existing literature around multidimensional environments and sleep health for aging adults.
Autor:
Margarethe E Goetz, Michele Marcus, Viola Vaccarino, Felicia Goldstein, Allan Levey, James Lah
Publikováno v:
Circulation. 135
Background: Family history of cardiovascular disease (CVD) is a readily available risk indicator of future CVD, combining the influence of shared genetic, environmental and behavioral risk factors. Though CVD risk factors have been associated with an